Follow-The-Filings

Security · featured owners

FULC Fulcrum Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 exit

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management exited 2026 Q2 last 2026 Q1 0.36% Exit −0.36% 205,000 $2M history

0 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 18 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 1.01,3.02,5.01,5.02,7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc
8-K 2.05,8.01 Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 1.02,2.02,5.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B5 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Jul 16, 2026 Filing Doc
4 Period Jul 13, 2026 Filing Doc
4 Period Jun 30, 2026 · 8 forms Filing Doc
4 Period Jun 26, 2026 Filing Doc
4 Period Apr 23, 2026 Filing Doc
4 Period Feb 2, 2026 · 5 forms Filing Doc
4/A Period Jan 2, 2026 Filing Doc
4 Period Jan 2, 2026 Filing Doc
4 Period Dec 15, 2025 Filing Doc
4 Period Dec 8, 2025 Filing Doc
4 Period Nov 19, 2025 Filing Doc

Updated 2 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$97.34M -$9.72M -$74.88M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $242.2M $249.92M $357.48M
Total non-current assets * $15.5M $10.8M $8.8M
Total assets $257.69M $260.72M $366.28M
Total current liabilities $13.68M $11.04M $13.05M
Total non-current liabilities * $8.83M $6.64M $4.24M
Total equity $235.19M $243.03M $349M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$90.96M -$2.22M -$60.06M
Cash from investing -$36.69M $32.23M $30.72M
Cash from financing $118.12M $2.75M $168.67M
Net change in cash -$9.54M $32.76M $139.32M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders